Evidence map›Paper›PMID 36590661›Full record

ArticleClinical case reports2022

Chronic myelogenous leukemia presenting with Morel Lavallée lesion: A case report of a rare presentation.

Sara S I Mohamed, Hana Mahmoud Qasim, Ahmed Mahfouz, Maab A Osman, Ashraf O E Ahmed, Safa H Al-Azewi, Mohamad A Yassin, Shehab Fareed

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sara S I MohamedInternal Medicine Department Hamad Medical Corporation Doha Qatar.
Hana Mahmoud QasimDivision of Hematology, Oncology Department, National Center for Cancer and Research Hamad Medical Corporation Doha Qatar.ORCID https://orcid.org/0000-0002-9354-6314
Ahmed MahfouzRadiology Department Hamad Medical Corporation Doha Qatar.
Maab A OsmanInternal Medicine Department Hamad Medical Corporation Doha Qatar.
Ashraf O E AhmedInternal Medicine Department Hamad Medical Corporation Doha Qatar.
Safa H Al-AzewiDivision of Hematology, Oncology Department, National Center for Cancer and Research Hamad Medical Corporation Doha Qatar.
Mohamad A YassinDivision of Hematology, Oncology Department, National Center for Cancer and Research Hamad Medical Corporation Doha Qatar.ORCID https://orcid.org/0000-0002-1144-8076
Shehab FareedDivision of Hematology, Oncology Department, National Center for Cancer and Research Hamad Medical Corporation Doha Qatar.
Hamad Medical Corporation · QANational Center for Cancer Care and Research · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic myelogenous leukemia is a myeloproliferative neoplasm characterized by the BCR-ABL1 fusion gene and the development of the Philadelphia chromosome, which leads to an increase in granulocytes and bone marrow myeloid precursors in the blood, it can lead to many possible complications depending on the disease stage at the time of diagnosis. The Morel-Lavallée lesion (MLL) is a closed traumatic soft-tissue degloving injury, that results from the separation of the hypodermis from the underlying fascia, with resultant hemo-lymphatic fluid collection between the tissue layers. We report a case of a 48-year-old male patient, with no chronic illnesses, who presented with 2 weeks history of posterior chest wall pain and swelling. Initial investigation showed a white blood cell count of 364.4 × 10

Indexed as

chronic myelogenous leukemiahematomaleukemiaMorel‐Lavallée

Identifiers

PMID36590661
PMCPMC9794922
OpenAlexW4312213949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.